| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 5 |
| 1 | TACROLIMUS | 5 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 5 |
| 3 | TACROLIMUS OINTMENT 0.1% | 5 |
| 4 | RITUXIMAB | 3 |
| 5 | CYCLOPHOSPHAMIDE | 2 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 8 | PREDNISOLONE | 2 |
| 9 | PREDNISOLONE ORAL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIMECROLIMUS | 1 | 0.0006 |
| 1 | GLOFITAMAB | 1 | 0.0004 |
| 2 | BENDAMUSTINE HCL | 1 | 0.0001 |
| 3 | OBINUTUZUMAB | 1 | 0.0001 |
| 4 | TACROLIMUS OINTMENT 0.1% | 5 | 0.0000 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 5 | 0.0000 |
| 6 | ERGOCALCIFEROL | 1 | 0.0000 |
| 7 | TACROLIMUS | 5 | 0.0000 |
| 8 | GEMCITABINE HYDROCHLORIDE | 1 | 0.0000 |
| 9 | RITUXIMAB | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 1 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 2 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 3 | Cardiac Glycoside [EPC] | 1 | 0.0000 |
| 4 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 3 | 0.0000 |
| 6 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |